Syncona (LON:SYNC) Hits New 52-Week High – Time to Buy?

Syncona (LON:SYNC)’s share price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 110.02 and last traded at GBX 110, with a volume of 8624 shares changing hands. The stock had previously closed at GBX 109.40.

Analyst Ratings Changes

Separately, Peel Hunt restated a “buy” rating and issued a GBX 189 price objective on shares of Syncona in a report on Tuesday, August 4th. One analyst has rated the stock with a Buy rating, According to MarketBeat, the stock presently has an average rating of “Buy” and an average target price of GBX 189.

Syncona Price Performance

The company has a fifty day simple moving average of GBX 105.24 and a two-hundred day simple moving average of GBX 98.21. The company has a market capitalization of £666.62 million, a P/E ratio of -75.59 and a beta of 0.36.

Insider Activity at Syncona

In related news, insider John Roche acquired 16,063 shares of the stock in a transaction dated Friday, June 19th. The shares were acquired at an average price of GBX 100 per share, with a total value of £16,063. Corporate insiders own 0.75% of the company’s stock.

About Syncona

Syncona’s purpose is to invest to extend and enhance human life. We do this by creating, building and scaling companies to deliver transformational treatments to patients in areas of high unmet need. We aim to build and maintain a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic area, for the benefit of all our stakeholders. We focus on developing treatments that deliver patient impact by working in close partnership with world-class academic founders and experienced management teams.